Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

MEHMET VAROL

DOÇENT

MUĞLA SITKI KOÇMAN ÜNİVERSİTESİ FEN FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ

Research topics OpenAlex
  1. Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  2. Yan Dal Moleküler Biyoloji ve Genetik
Keywords YÖKSİS
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 39
YÖKSİS39 OpenAlex0
Projects 10
Books 10
Proceedings 25

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 35
h-index 18 Percentile in Türkiye: 97 #20 of 1,316 at their university by h-index
i10-index
25
Total citations
2,463
Top 1.1% in Türkiye
Per article
70.4
FWCI
3.97
1.00 = world average
World top 1%
3
World top 10%
12

Most cited articles

  1. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements 2019 world top 1% 1,236 citations
  2. Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements 2020 world top 1% 240 citations
  3. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement 2022 world top 1% 223 citations

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 35
  • Q1 12 %34.3
  • Q2 11 %31.4
  • Q3 8 %22.9
  • Q4 4 %11.4
WoS (JCR) 29
  • Q1 7 %24.1
  • Q2 12 %41.4
  • Q3 7 %24.1
  • Q4 3 %10.3
TR Index 1 articles
OpenAlex citation percentile
Top 1%3
Top 10%12
Avg · n 35 %80.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 35

WoS (JCR)

  • YÖKSİS rows 29

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

39articles

Journals with publications

29 journals

Narrow down

Scopus (SJR)
Q112 Q211 Q38 Q44
WoS (JCR)
Q17 Q212 Q37 Q43
TR Index
1articles

Article list

  1. 2025 Exploring Urtica dioica L. as a Promising Alternative Therapy for Obesity-Related Breast Cancer: Insights from Molecular Mechanisms and Bioinformatic Analysis Plant Foods for Human Nutrition DOI 10.1007/s11130-025-01341-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.9%
  2. 2024 Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY DOI 10.1007/s00210-023-02699-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 58.1%
  3. 2024 Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics Journal of Controlled Release DOI 10.1016/j.jconrel.2024.05.032 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.2%
  4. 2024 New Schiff Base Derived Organotin (IV) Complexes: Synthesis, Characterization, In vitro and In silico Biological Studies Anti-Infective Agents DOI 10.2174/0122113525305623240409075331 YÖKSİS SJR Q4 OpenAlex 35.0%
  5. 2023 Chemopreventive mechanisms of amentoflavone: recent trends and advancements NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY DOI 10.1007/s00210-023-02416-6 YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.7%
  6. 2023 Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis Archives of Toxicology DOI 10.1007/s00204-022-03421-z YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.1%
  7. 2023 Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions Journal of Nanostructure in Chemistry DOI 10.1007/s40097-022-00504-2 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.3%
  8. 2022 Phloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactions Molecules DOI 10.3390/molecules27248819 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 94.9%
  9. 2022 STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation Molecular Biology Reports DOI 10.1007/s11033-022-07399-w YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.6%
  10. 2022 Organotin (IV) complexes derived from Schiff base 1,3-bis[(1E)-1-(2-hydroxyphenyl)ethylidene] thiourea: synthesis, spectral investigation and biological study to molecular docking Journal of the Iranian Chemical Society DOI 10.1007/s13738-021-02430-6 YÖKSİS SJR Q3 JCR Q3 OpenAlex 74.5%
  11. 2022 Synthesis, Structural Investigations, and In Vitro/In Silico Bioactivities of Flavonoid Substituted Biguanide: A Novel Schiff Base and Its Diorganotin (IV) Complexes Molecules DOI 10.3390/molecules27248874 YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.8%
  12. 2022 Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/1871520621666210223095021 YÖKSİS SJR Q3 JCR Q3 OpenAlex 79.5%
  13. 2022 Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments Toxin Reviews DOI 10.1080/15569543.2021.2024576 YÖKSİS SJR Q3 JCR Q2 OpenAlex 85.3%
  14. 2022 Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects OncoTargets and Therapy DOI 10.2147/OTT.S366630 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 93.8%
  15. 2022 Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone Pharmaceuticals DOI 10.3390/ph15111418 YÖKSİS SJR Q1 JCR Q2 OpenAlex 85.8%
  16. 2022 Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement Seminars in Cancer Biology DOI 10.1016/j.semcancer.2020.05.011 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
  17. 2022 Antimicrobial screening to molecular docking of newly synthesized ferrocenyl-substituted pyrazole International Journal of Health Sciences DOI https://ijhs.org.sa/index.php/journal/article/view/6053/1110 YÖKSİS JCR Q2
  18. 2022 Synthesis, Spectral Investigations, Biological Potential and Molecular\nDocking Study of Novel Schiff Base and its Transition Metal Complexes Anti-Infective Agents DOI 10.2174/2211352519666211104090749 YÖKSİS SJR Q4 OpenAlex 51.1%
  19. 2021 Deguelin targets multiple oncogenic signaling pathways to combat human malignancies Pharmacological Research DOI 10.1016/j.phrs.2021.105487 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.1%
  20. 2021 Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets Toxicology in Vitro DOI 10.1016/j.tiv.2021.105142 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 92.6%

← Back to academicians